Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides

1. G. Padmanaban and P. N. Rangarajan, Heme metabolism of Plasmodium is a major antimalarial target, Biochem. Biophys. Res. Commun. 268 (2000) 665–668; https://doi.org/10.1006/bbrc.1999.189210.1006/bbrc.1999.189210679261Search in Google Scholar

2. C. Even, S. Friedman and K. Lamouar, Bipolar disorder after mefloquine treatment, J. Psychiatry Neurosci. 26 (2001) 252–253.Search in Google Scholar

3. F. de Pilla Varotti, A. C. C. Botelho, A. A. Andrade, R. C. de Paula, E. M. S. Fagundes, A. Valverde, L. M. U. Mayer, J. S. Mendonça, M. V. N. de Souza, N. Boechat and A. U. Krettli, Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate, Antimicrob. Agents Chemother. 52 (2008) 3868–3874; https://doi.org/10.1128/AAC.00510-0810.1128/AAC.00510-08257309818710907Search in Google Scholar

4. A. R. Hamann, C. de Kock, P. J. Smith, W. A. L. van Otterlo and M. A. L. Blackie, Synthesis of novel triazole-linked mefloquine derivatives: Biological evaluation against Plasmodium falciparum, Bioorg. Med. Chem. Lett. 24 (2014) 5466–5469; https://doi.org/10.1016/j.bmcl.2014.10.01510.1016/j.bmcl.2014.10.01525455485Search in Google Scholar

5. N. Sharma, S. Thomas, E. B. Golden, F. M. Hofman, T. C. Chen, N. A. Petasis, A. H. Schönthal and S. G. Louie, Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent, Cancer Lett. 326 (2012) 143–154; https://doi.org/10.1016/j.canlet.2012.07.02910.1016/j.canlet.2012.07.02922863539Search in Google Scholar

6. F. A. Rodrigues, I. S. Bomfim, B. C. Cavalcanti, C. Pessoa, R. S. Goncalves, J. L. Wardell, S. M. Wardell and M. V. de Souza, Mefloquine-oxazolidine derivatives: A new class of anticancer agents, Chem. Biol. Drug Des. 83 (2014) 126–131; https://doi.org/10.1111/cbdd.1221010.1111/cbdd.1221023961998Search in Google Scholar

7. T. Küster, B. Stadelmann, R. Rufener, C. Risch, J. Müller and A. Hemphill, Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin, Int. J. Antimicrob. Agents46 (2015) 546–551; https://doi.org/10.1016/j.ijantimicag.2015.07.01610.1016/j.ijantimicag.2015.07.01626395219Search in Google Scholar

8. L. E. Bermudez, P. Kolonoski, L. E. Seitz, M. Petrofsky, R. Reynolds, M. Wu and L. S. Young, SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease, Antimicrob. Agents Chemother. 48 (2004) 3556–3558; https://doi.org/10.1128/AAC.48.9.3556-3558.200410.1128/AAC.48.9.3556-3558.200451478815328125Search in Google Scholar

9. L. Danelishvili, M. Wu, L. S. Young and L. E. Bermudez, Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in Mycobacteria, Antimicrob. Agents Chemother. 49 (2005) 3707–3714; https://doi.org/10.1128/AAC.49.9.3707-3714.200510.1128/AAC.49.9.3707-3714.2005119544516127044Search in Google Scholar

10. R. S. Gonçalves, C. R. Kaiser, M. C. Lourenço, F. A. Bezerra, M. V. de Souza, J. L. Wardell, S. M. Wardell, M. D. Henriques and T. Costa, Mefloquine-oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113, Bioorg. Med. Chem. 20 (2012) 243–248; https://doi.org/10.1016/j.bmc.2011.11.00610.1016/j.bmc.2011.11.00622142615Search in Google Scholar

11. J. Mao, H. Yuan, Y. Wang, B. Wan, D. Pak, R. He and S. G. Franzblau, Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs, Bioorg. Med. Chem. Lett. 20 (2010) 1263–1268; https://doi.org/10.1016/j.bmcl.2009.11.10510.1016/j.bmcl.2009.11.10520022500Search in Google Scholar

12. S. Eswaran, A. V. Adhikari, I. H. Chowdhury, N. K. Pal and K. D. Thomas, New quinoline derivatives: Synthesis and investigation of antibacterial and antituberculosis properties, Eur. J. Med. Chem. 45 (2010) 3374–3383; https://doi.org/10.1016/j.ejmech.2010.04.02210.1016/j.ejmech.2010.04.02220537437Search in Google Scholar

13. G. Džimbeg, B. Zorc, M. Kralj, K. Ester, K. Pavelić, J. Balzarini, E. De Clercq and M. Mintas, The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations, Eur. J. Med. Chem. 43 (2008) 1180–1187; https://doi.org/10.1016/j.ejmech.2007.09.00110.1016/j.ejmech.2007.09.00117961851Search in Google Scholar

14. M. Šimunović, I. Perković, B. Zorc, K. Ester, M. Kralj, D. Hadjipavlou-Litina and E. Pontiki, Urea and carbamate derivatives of primaquine: synthesis, cytostatic and antioxidant activities, Bioorg. Med. Chem. 17 (2009) 5605–5613; https://doi.org/10.1016/j.bmc.2009.06.03010.1016/j.bmc.2009.06.03019581098Search in Google Scholar

15. I. Perković, S. Tršinar, J. Žanetić, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina and A. M. Katsori, Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine – synthesis, cytostatic, antiviral and antioxidative studies, J. Enzyme Inhib. Med. Chem. 28 (2013) 601–610; https://doi.org/10.3109/14756366.2012.66336610.3109/14756366.2012.66336622380782Search in Google Scholar

16. K. Pavić, I. Perković, M. Cindrić, M. Pranjić, I. Martin-Kleiner, M. Kralj, D. Schols, D. Hadjipavlou-Litina, A.-M. Katsori and B. Zorc, Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: Synthesis, cytostatic and antioxidative activity, Eur. J. Med. Chem. 86 (2014) 502–514; https://doi.org/10.1016/j.ejmech.2014.09.01310.1016/j.ejmech.2014.09.01325203780Search in Google Scholar

17. I. Perković, M. Antunović, I. Marijanović, K. Pavić, K. Ester, M. Kralj, J. Vlainić, I. Kosalec, D. Schols, D. Hadjipavlou-Litina, E. Pontiki and B. Zorc, Novel urea and bis-urea primaquine derivatives with hydroxyphenyl and halogenphenyl substituents: synthesis and biological evaluation, Eur. J. Med. Chem. 124 (2016) 622–636; https://doi.org/10.1016/j.ejmech.2016.08.02110.1016/j.ejmech.2016.08.02127614409Search in Google Scholar

18. K. Pavić, I. Perković, P. Gilja, F. Kozlina, K. Ester, M. Kralj, D. Schols, D. Hadjipavlou-Litina, E. Pontiki and B. Zorc, Design, synthesis and biological evaluation of novel primaquine-cinnamic acid conjugates of amide and acylsemicarbazide type, Molecules21 (2016) 1629–1653; https://doi.org/10.3390/molecules2112162910.3390/molecules21121629627368727916811Search in Google Scholar

19. K. Pavić, I. Perković, Š. Pospíšilová, M. Machado, D. Fontinha, M. Prudêncio, J. Jampilek, A. Coffey, L. Endersen, H. Rimac and B. Zorc, Primaquine hybrids as promising antimycobacterial and antimalarial agents, Eur. J. Med. Chem. 143 (2018) 769–779; https://doi.org/10.1016/j.ejmech.2017.11.08310.1016/j.ejmech.2017.11.08329220797Search in Google Scholar

20. J. Vlainić, I. Kosalec, K. Pavić, D. Hadjipavlou-Litina, E. Pontiki and B. Zorc, Insights into biological activity of ureidoamides with primaquine and amino acid moieties, J. Enzyme Inhib. Med. Chem. 33 (2018) 376–382; https://doi.org/10.1080/14756366.2017.142306710.1080/14756366.2017.1423067602103529363364Search in Google Scholar

21. J. Levatić, K. Pavić, I. Perković, L. Uzelac, K. Ester, M. Kralj, M. Kaiser, M. Rottmann, F. Supek and B. Zorc, Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity, Eur. J. Med. Chem. 146 (2018) 651–667; https://doi.org/10.1016/j.ejmech.2018.01.06210.1016/j.ejmech.2018.01.06229407988Search in Google Scholar

22. M. Beus, Z. Rajić, D. Maysinger, Z. Mlinarić, M. Antunović, I. Marijanović, D. Fontinha, M. Prudêncio, J. Held, S. Olgen and B. Zorc, SAHAquines, novel hybrids based on SAHA and primaquine motifs, as potential anticancer and antiplasmodial agents, ChemistryOpen7 (2018) 624–638; https://doi.org/10.1002/open.20180011710.1002/open.201800117610443330151334Search in Google Scholar

23. Z. Rajić, M. Beus, H. Michnova, J. Vlainić, L. Persoons, I. Kosalec, J. Jampilek, D. Schols, T. Keser and B. Zorc, Asymmetric primaquine and halogenaniline fumardiamides as novel biologically active Michael acceptors, Molecules23 (2018) Article ID 1724 (18 pages); https://doi.org/10.3390/molecules2307172410.3390/molecules23071724610058230011922Search in Google Scholar

24. I. Zhang, M. Beus, U. Stochaj, P. U. Le, B. Zorc, Z. Rajić, K. Petrecca and D. Maysinger, Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule, Cell Death Discov. 4 (2018) Article ID 41; https://doi.org/10.1038/s41420-018-0103-010.1038/s41420-018-0103-0615828830302275Search in Google Scholar

25. A. M. Mendes, I. S. Albuquerque, M. Machado, J. Pissarra, P. Meireles and M. Prudêncio, Inhibition of Plasmodium liver infection by ivermectin, Antimicrob. Agents Chemother. 61 (2017) e02005-16; https://doi.org/10.1128/AAC.02005-1610.1128/AAC.02005-16527874227895022Search in Google Scholar

26. J. Held, T. Gebru, M. Kalesse, R. Jansen, K. Gerth, R. Müller and B. Mordmüller, Antimalarial activity of the myxobacterial macrolide chlorotonil A, Antimicrob. Agents Chemother. 58(2014) 6378–6384; https://doi.org/10.1128/AAC.03326-1410.1128/AAC.03326-14424938225114138Search in Google Scholar

27. H. Noedl, J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch and M. Fukuda, Simple histidinerich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing, Antimicrob. Agents Chemother. 49 (2005) 3575–3577; https://doi.org/10.1128/AAC.49.8.3575-3577.200510.1128/AAC.49.8.3575-3577.2005119622316048989Search in Google Scholar

28. R Core Team, 2015, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; https://www.R-project.org/; last access December 15, 2018Search in Google Scholar

29. E. Borenfreund and J. A. Puerner, A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90), J. Tissue Culture Method9 (1985) 7–9; https://doi.org/10.1007/BF0166603810.1007/BF01666038Search in Google Scholar

30. Chemicalize, 2017, ChemAxon Ltd., Budapest, Hungary; https://chemicalize.com; last access November 28, 2018Search in Google Scholar

31. SwissADME Programs, Swiss Institute of Bioinformatics, Lausanne, Switerland; http://www.swissadme.ch; last access November 28, 2018Search in Google Scholar